Skip to Content

BlackRock Sus Adg Intl Eq Ins BRZIX

Medalist Rating as of | See BlackRock Investment Hub
  • NAV / 1-Day Return 11.12  /  +1.46 %
  • Total Assets 15.3 Mil
  • Adj. Expense Ratio
    0.500%
  • Expense Ratio 0.500%
  • Distribution Fee Level Low
  • Share Class Type Institutional
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 2.0 Mil
  • Status Open
  • TTM Yield 2.44%
  • Turnover 118%

USD | NAV as of Apr 22, 2024 | 1-Day Return as of Apr 22, 2024, 10:15 PM GMT+0

Morningstar’s Analysis BRZIX

Will BRZIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A strong management team and sound investment process underpin BlackRock Sus Adg Intl Eq Ins's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BRZIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 20.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

3.12 506,717
Healthcare

ASML Holding NV

2.98 483,715
Technology

BlackRock Liquidity T-Fund Instl

2.26 366,910
Cash and Equivalents

Nestle SA

2.16 351,767
Consumer Defensive

AstraZeneca PLC

1.95 317,396
Healthcare

SAP SE

1.95 316,318
Technology

Novartis AG Registered Shares

1.85 300,707
Healthcare

Shell PLC

1.67 271,815
Energy

Siemens AG

1.56 254,376
Industrials

Tokyo Electron Ltd

1.44 233,467
Technology